Relationship between Antibody 2F5 Neutralization of HIV-1 and Hydrophobicity of Its Heavy Chain Third Complementarity-Determining Region

被引:92
|
作者
Ofek, Gilad [1 ]
McKee, Krisha [1 ]
Yang, Yongping [1 ]
Yang, Zhi-Yong [1 ]
Skinner, Jeff [2 ]
Guenaga, F. Javier [1 ]
Wyatt, Richard [1 ]
Zwick, Michael B. [3 ]
Nabel, Gary J. [1 ]
Mascola, John R. [1 ]
Kwong, Peter D. [1 ]
机构
[1] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
[2] NIAID, Bioinformat & Computat Biosci Branch, Off Cyber Infrastruct & Computat Biol, NIH, Bethesda, MD 20892 USA
[3] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; TRANSITION-STATE ANALOG; MONOCLONAL-ANTIBODIES; VENOM PHOSPHOLIPASE-A2; ENVELOPE GLYCOPROTEIN; ECTODOMAIN REGION; CRYSTAL-STRUCTURE; GP41; ECTODOMAIN; ANTI-GP41; 2F5; MEMBRANE;
D O I
10.1128/JVI.02257-09
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The membrane-proximal external region (MPER) of the HIV-1 gp41 transmembrane glycoprotein is the target of the broadly neutralizing antibody 2F5. Prior studies have suggested a two-component mechanism for 2F5-mediated neutralization involving both structure-specific recognition of a gp41 protein epitope and nonspecific interaction with the viral lipid membrane. Here, we mutationally alter a hydrophobic patch on the third complementarity-determining region of the heavy chain (CDR H3) of the 2F5 antibody and assess the abilities of altered 2F5 variants to bind gp41 and to neutralize diverse strains of HIV-1. CDR H3 alterations had little effect on the affinity of 2F5 variants for a peptide corresponding to its gp41 epitope. In contrast, strong effects and a high degree of correlation (P < 0.0001) were found between virus neutralization and CDR H3 hydrophobicity, as defined by predicted free energies of transfer from water to a lipid bilayer interface or to octanol. The effect of CDR H3 hydrophobicity on neutralization was independent of isolate sensitivity to 2F5, and CDR H3 variants with tryptophan substitutions were able to neutralize HIV-1 similar to 10-fold more potently than unmodified 2F5. A threshold was observed for increased hydrophobicity of the 2F5 CDR H3 loop beyond which effects on 2F5-mediated neutralization leveled off. Together, the results provide a more complete understanding of the 2F5 mechanism of HIV-1 neutralization and indicate ways to enhance the potency of MPER-directed antibodies.
引用
收藏
页码:2955 / 2962
页数:8
相关论文
共 50 条
  • [31] De Novo Design and Biophysical Characterization of an Affinity-Enhanced Protein Displaying the Structure of the Broadly Neutralizing HIV-1 2F5 Antibody Epitope
    Viana, Isabelle Freire Tabosa
    Nascimento, Eduardo
    Craigo, Jodi
    Krieger, Marco
    Mailliard, Robbie
    Dhalia, Rafael
    Lins, Roberto
    Marques, Ernesto T. A.
    BIOPHYSICAL JOURNAL, 2016, 110 (03) : 346A - 346A
  • [32] The immunoglobulin CH1 constant region modulates antigen binding affinity and functional activities of the broadly neutralizing 2F5 HIV specific antibody
    Daniela Tudor
    Anne-Sophie Drillet
    Isabelle Schwartz-Cornil
    Ruizhong Shen
    Phillip D Smith
    Morgane Bomsel
    Retrovirology, 7
  • [33] The immunoglobulin CH1 constant region modulates antigen binding affinity and functional activities of the broadly neutralizing 2F5 HIV specific antibody
    Tudor, Daniela
    Drillet, Anne-Sophie
    Schwartz-Cornil, Isabelle
    Shen, Ruizhong
    Smith, Phillip D.
    Bomsel, Morgane
    RETROVIROLOGY, 2010, 7 : 22 - 22
  • [34] Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial
    Easterhoff, David
    Moody, M. Anthony
    Fera, Daniela
    Cheng, Hao
    Ackerman, Margaret
    Wiehe, Kevin
    Saunders, Kevin O.
    Pollara, Justin
    Vandergrift, Nathan
    Parks, Rob
    Kim, Jerome
    Michael, Nelson L.
    O'Connell, Robert J.
    Excler, Jean-Louis
    Robb, Merlin L.
    Vasan, Sandhya
    Rerks-Ngarm, Supachai
    Kaewkungwal, Jaranit
    Pitisuttithum, Punnee
    Nitayaphan, Sorachai
    Sinangil, Faruk
    Tartaglia, James
    Phogat, Sanjay
    Kepler, Thomas B.
    Alam, S. Munir
    Liao, Hua-Xin
    Ferrari, Guido
    Seaman, Michael S.
    Montefiori, David C.
    Tomaras, Georgia D.
    Harrison, Stephen C.
    Haynes, Barton F.
    PLOS PATHOGENS, 2017, 13 (02)
  • [35] Structure-affinity relationships in the gp41 ELDKWA epitope for the HIV-1 neutralizing monoclonal antibody 2F5:: effects of side-chain and backbone modifications and conformational constraints
    Tian, Y
    Ramesh, CV
    Ma, X
    Naqvi, S
    Patel, T
    Cenizal, T
    Tiscione, M
    Diaz, K
    Crea, T
    Arnold, E
    Arnold, GF
    Taylor, JW
    JOURNAL OF PEPTIDE RESEARCH, 2002, 59 (06): : 264 - 276
  • [36] Identification of a conserved self-antigen bearing the 2F5 neutralizing epitope of the HIV-1 gp41 Membrane Proximal External Region
    Yang, Guang
    Holl, T.
    Liu, Yang
    Li, Yi
    Lu, Xiaozhi
    Nicely, Nathan
    Kepler, Thomas
    Alam, S.
    Liao, Hua-xin
    Spicer, Leonard
    Haynes, Barton
    Kelsoe, Garnett
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [37] Recognizing a dynamic HIV-1 target: a structural look at the interaction between bnAb 2F5 and varying gp41 MPER sequences
    Julien, J.
    Bryson, S.
    Hynes, R. C.
    Pai, E. F.
    RETROVIROLOGY, 2009, 6
  • [38] Stable recombinant expression of the anti HIV-1 monoclonal antibody 2F5 after IgG3/IgG1 subclass switch in CHO cells
    Kunert, R
    Steinfellner, W
    Purtscher, M
    Assadian, A
    Katinger, H
    BIOTECHNOLOGY AND BIOENGINEERING, 2000, 67 (01) : 97 - 103
  • [39] P12-12. Analysis of antibody and B cell responses following inoculation with computationally designed HIV-1 2F5 epitope scaffold proteins
    P Dosenovic
    J Guenaga
    G Ofek
    D Baker
    W Schief
    PD Kwong
    GB Karlsson Hedestam
    RT Wyatt
    Retrovirology, 6
  • [40] Structure and Immunogenicity of a Peptide Vaccine, Including the Complete HIV-1 gp41 2F5 Epitope IMPLICATIONS FOR ANTIBODY RECOGNITION MECHANISM AND IMMUNOGEN DESIGN
    Serrano, Soraya
    Araujo, Aitziber
    Apellaniz, Beatriz
    Bryson, Steve
    Carravilla, Pablo
    de la Arada, Igor
    Huarte, Nerea
    Rujas, Edurne
    Pai, Emil F.
    Arrondo, Jose L. R.
    Domene, Carmen
    Angeles Jimenez, Maria
    Nieva, Jose L.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (10) : 6565 - 6580